Structure Therapeutics Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
GPCR on Nasdaq
Location
611 Gateway Blvd Suite 223, South San Francisco, CA

Insiders trading volume in the past year

Structure Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fmr Llc Other*, 10%+ Owner $55.2M -$795K -1.42% Jun 6, 2024
Ramy Farid Director $17.2M Feb 7, 2023
Daniel G. Welch Director $7.76M Jun 25, 2024
Raymond C. Stevens CHIEF EXECUTIVE OFFICER, Director $2.88M -$9.77M -77.2% Jun 12, 2024
Xichen Lin Chief Scientific Officer $1.7M -$1.68M -49.7% Jun 3, 2024
Jun Yoon Chief Financial Officer $1.18M Mar 15, 2024
Yingli Ma Chief Technology Officer $729K Mar 15, 2024
Ted W. Love Director $598K Jun 25, 2024
Mark Allen Bach Chief Medical Officer $521K Mar 15, 2024
Melita Sun Jung Chief Business Officer $62.5K Feb 7, 2023
Eric Dobmeier Director Jun 25, 2024
Ashley Hall Chief Development Officer Sep 18, 2024
Angus C. Russell Director Aug 26, 2024
Bvf Partners L P/Il 10%+ Owner May 10, 2023
Sharon Tetlow Director Jun 25, 2024
Crespo Blas Coll Chief Medical Officer Sep 18, 2024
FIL Ltd Other* Feb 7, 2023
Joanne Waldstreicher Director Jun 25, 2024

Recent Insider Transactions by Companies or Individuals for Structure Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.